Abstract
Introduction
Rheumatoid arthritis (RA) is characterized by chronic inflammation at multiple joints. T and B lymphocytes and macrophages infiltrate into the affected synovial tissues, and promote release of a high concentration of proinflammatory cytokines, including tumor necrosis factor (TNF)-α and IL-1 (1) . In response to these cytokines, synovial fibroblasts proliferate vigorously and form pannus tissues, which destroy the cartilage and bone of the joints. In clinics, various drugs are used to control RA. Representative are conventional disease-modifying anti-rheumatic drugs including hydroxychloroquine, D-penicillamine, gold, sulfasalazine as well as immunosuppressive methotrexate. Although they do not have distinct target molecules known to be responsible for their anti-rheumatic effects, they appear to down-modulate the inflammatory processes (2) . In contrast, newly developed drugs, such as leflunomide, cyclosporin A and FK506, inhibit intracellular molecules essential for activation of the immunocompetent cells involved in the rheumatoid synovitis. TNF-α antagonists (remicade and infliximab) neutralize the key inflammatory mediator released by the synovial cells. Many patients respond well to these drugs, but some are resistant or become so after some period of disease amelioration. Moreover, few have been proven effective in halting the disease progression in the long term. We assume that suppression of one inflammatory mediator might activate other mediators because of redundancy of the inflammatory pathways. Thus, suppression of the synovial cell proliferation itself seems to be the most effective therapeutic way to intervene in the joint destruction.
In general, cell cycle progression of eukaryotic cells is regulated largely by kinase activity of cyclin/cyclin-dependent kinase (CDK) complexes. There are several subtypes of cyclins and CDK, which undergo cyclic activation to promote cell cycle progression (3) . The kinase activity is inhibited by a group of intranuclear proteins termed CDK inhibitors (CDKI).
Up to now, two CDKI families have been identified (3) . They are the INK4 family, which consists of p16 INK4a , p15 INK4b , p18 INK4c and p19 INK4d , and the Cip/Kip family, which consists of p21 Cip1 , p27 Kip1 and p57 Kip2 . Previously, we investigated expression of cell-cycle proteins in rheumatoid synovial fibroblasts (RSF) (4). We found that p16 INK4a and p21 Cip1 expression was readily induced in vitro in RSF derived from joints with active synovitis. This induction was observed when growth of RSF was artificially inhibited. Of note, the induction of p16 INK4a was characteristic of RSF, but not of other types of fibroblasts. Subsequently, using adjuvant arthritis (AA) of rats, an animal model of RA, we showed that adenoviral transfer of the p16 INK4a gene to the synovial tissues suppressed pathology of the arthritis (4). This was the first evidence showing that cell-cycle control of synovial cells is effective for arthritis treatment. The p16 INK4a protein binds specifically to CDK4 and CDK6, and inhibits formation of the CDK/cyclin complexes (3). Physiologically, it is expressed by replicative senescent cells and by terminally differentiated cells (5) . Forced expression of the p16 INK4a gene induces cell-cycle arrest at G 1 phase and phenotypic changes characteristic of senescent cells (6) .
The p21 Cip1 protein, being the other one of the two inducible CDKI in RSF, inhibits a wide variety of cyclin/CDK complexes (3). Forced expression of p21 Cip1 also arrests the cell cycle of normal and tumor cells at the G 1 phase (7). In fibroblasts, the expression level of p21 Cip1 goes up with an increase of cell division and decreases when the cells approach senescence (8) . In contrast, the p16 INK4a protein level gradually rises and stays high in the senescent cells. Thus, p16 INK4a gene expression appears to have a more direct impact in senescence induction (5) . The biological function of p21 Cip1 is more complex. In certain settings, p21 Cip1 promotes formation of active kinase complexes by cyclin and CDK, forwarding rather than halting the cell cycle (9) . Whereas the N-terminal domain interacts with CDK/cyclin complexes, the C-terminal domain binds to and inhibits proliferation cell nuclear antigen (PCNA), a subunit of DNA polymerase δ, which is essential for DNA replication and repair (10) . Also, the expression of p21 Cip1 enhances NF-κB-dependent gene expression by inhibiting cyclin E/CDK2, which binds to complexes of p300/ CBP co-activators and NF-κB (11) . In this regard, NF-κB is a critical transcription factor involved in rheumatoid synovitis (12) . Whereas proinflammatory cytokines such as IL-1 and TNF-α activate NF-κB in rheumatoid synovial tissues, the production of these cytokines depends on NF-κB (13, 14) . Moreover, forced expression of p21 Cip1 induced apoptotic cell death of some cell lines (15) (16) (17) (18) .
Thus, p21 Cip1 ectopically expressed in the inflamed synovial tissues may exert differential effects than p16 INK4a on the pathology of the arthritis. In the present study, we first transferred the p21 Cip1 gene adenovirally into RSF. Subsequently, the gene was transferred in vivo to synovial tissues of rats with AA, which had been treated successfully with p16 INK4a gene therapy. The results revealed that p21 Cip1 is also a potentially ideal target for development of gene therapy as well as anti-rheumatic drugs.
Methods

Recombinant adenoviruses
A recombinant replication-defective adenovirus, AxCAp21, containing a CAG promoter and a human p21 Cip1 gene was prepared (19) . An AxCALacZ adenovirus containing a bacterial lacZ gene was a gift from Dr Saito (20) . An Ax1w1 adenovirus without insertion was purchased from the Riken Gene Bank (Saitama, Japan). Previous studies showed that the product of the p21 Cip1 gene in the AxCAp21 virus can inhibit CDK activity and thus keep pRB protein underphosphorylated (21) .
Cell culture
Synovial tissues were obtained from five patients, under their consent, who underwent synovectomy or total knee joint replacement surgery for active rheumatoid synovitis at Nippon Medical School Hospital, Tokyo Metropolitan Bokuto or Huchu Hospital. They fulfilled the American College of Rheumatology criteria for classification of RA (22) . RSF were isolated and cultured as described elsewhere (4) . The cells at passages 3-6 were used for experiments.
Cell proliferation assay
In vitro adenoviral infection was performed as described previously (19) . Cell growth was assessed by incorporation of [ 3 H]thymidine. RSF were plated in 96-well plates, incubated in 10% FBS for 24 h and then infected with various concentrations of the adenoviruses for 1 h. Then the cells were incubated for 48 h. For the last 24 h, the cells were pulsed with [ 3 H]thymidine (Amersham, Little Chalfont, UK) and then incorporated radioactivities counted.
Apoptosis assays
A half million RSF were infected with 5ϫ10 7 p.f.u. of the AxCAp21 or Ax1w1 adenoviruses at 100 m.o.i. To induce apoptosis, the same number of cells were treated with 50 µM N-acetylsphingosine (Wako Pure Chemical, Osaka, Japan) in RPMI 1640 medium supplemented with 40 ng/ml plateletderived growth factor (PDGF; Genzyme, Cambridge, MA) (23). After 4 days, the treated cells were isolated with trypsin-EDTA solution (Immunobiology Laboratories, Gunma, Japan), fixed with 1% glutaraldehyde in PBS and stained with Hoechst 33258 (Molecular Probes, Eugene, OR). To quantify the apoptotic cells, 500 nuclei were visually examined. Total cellular DNA was extracted from the treated cells and their fragmentation was analyzed with 2% agarose gel DNA electrophoresis.
Gene therapy of AA Six-week-old male Lewis rats were immunized with 1 mg of Mycobacterium butyricum emulsified in 100 µl of mineral oil. Intra-articular gene transfer to the knee joints was carried out by injecting 1ϫ10 7 p.f.u. of the adenoviruses in 50 µl of saline. During the course of the disease, severity of the arthritis was clinically scored (24) . Width of the knee joints at the lower edge of the patella was measured by a micrometer. At the end of the clinical observation, the joints were fixed for histological and immunohistochemical analyses. Injections of saline alone served as a control. All procedures in these animal experiments were reviewed and approved the Institutional Animal Care and Use Committee of Tokyo Medical and Dental University (approval no. 990107), and carried out under the control of the guidelines for animal experiments.
Histological analysis
The knee joints were embedded in paraffin wax after 10% PBS-formalin fixation and decalcification. Their sections (5 µm) were stained with hematoxylin & eosin. Thickness of the synovial tissues and cartilage was measured at the position close to the synovial attachment to the tibial head. Mononuclear cells in 1.8ϫ10 -8 m 2 of the synovial tissues were enumerated at the same position. Severity of the pannus invasion was scored as was performed previously (4).
Immunohistochemistry
For immunohistochemical analyses, the fixed sections (5 µm) were deparaffinized and treated by two rounds of microwave heating for 5 min in 10 µM sodium citrate (pH 6). They were incubated with 0.3% H 2 O 2 , with 10% normal goat serum in PBS and with an anti-PCNA mAb (PC10; Santa Cruz Biotechnology, Santa Cruz, CA) or a control mouse IgG antibody for 1 h. This antibody reacts with a PCNA peptide chain distinct from the binding site for p21 Cip1 , ruling out the possibility that binding of p21 Cip1 to PCNA interferes with the antibody reactivity (25, 26) . They were subsequently incubated with a biotinylated goat anti-mouse IgG antibody (AP181B; Chemicon, Temecula, CA) and with horseradish peroxidaselabeled streptavidin (Southern Biotechnology Associates, Birmingham, AL). Bound antibodies were visualized with 0.02% 3,3Ј-diaminobenzidine tetrahydrochloride. The sections were counterstained with hematoxylin. The percentages of the PCNA ϩ cells in total cells [PCNA labeling indices (LI)] were calculated by examining 200 synovial cells (27) .
Statistics
Statistical analyses were carried out with StatView-5.0J software (SAS, Cary, NC). The [ 3 H]thymidine uptake of the cultured RSF, as well as knee width, thickness of the cartilage and synovial membranes and PCNA LI of the AxCAp21-treated and AxCALacZ-treated joints were compared with a paired t-test. The scores of pannus invasion were compared with a Mann-Whitney U-test. The percentages of the apoptotic RSF infected with the adenoviruses were compared with a t-test.
Results
Growth inhibition of RSF by the p21 Cip1 gene transfer
Using recombinant adenoviruses, the effect of the ectopic expression of p21 Cip1 on proliferation of RSF was evaluated. RSF were cultured to allow logarithmic growth with media containing 10% FBS. They were infected with the AxCAp21 adenoviruses containing a human p21 Cip1 gene or with the Ax1w1 adenoviruses containing no inserted gene. Western blot analysis of the total cell lysates of the infected cells showed that the p21 Cip1 protein was expressed specifically by the AxCAp21-infected cells but not by the Ax1w1-infected cells (data not shown). Proliferation of the cells was evaluated 24 h after the infection. Compared to the proliferation of the Ax1w1-infected RSF, that of the AxCAp21-infected RSF was significantly suppressed by the viruses. The suppressive effect depended on the titer of the viruses (Fig. 1) .
Apoptotic cell death of RSF with the overexpressed p21 Cip1 gene
Growth inhibition observed in the AxCAp21-infected RSF could be due to apoptosis induced by the ectopic p21 Cip1 expression. Thus, RSF infected with the AxCAp21 adenoviruses and those infected with the Ax1w1 adenoviruses were examined for apoptotic cell death.
As was reported previously, RSF undergo apoptotic cell death when they are treated with N-acetylsphingosine (23) . The apoptotic RSF displayed characteristic morphological changes such as nuclear condensation and fragmentation when they were stained with Hoechst 33258 (Fig. 2A) . The RSF treated with a growth-inhibitory concentration (100 m.o.i.) of AxCAp21 or those with the same dose of Ax1w1 were also stained 4 days after the infection (Fig. 2B and C) . They were compared with RSF cultured without the viruses (Fig. 2D) . The percentages of apoptotic cells that showed characteristic nuclear changes were evaluated in three different samples for each type of the infection. The frequencies of the apoptotic cells in the non-infected, AxCAp21-infected and Ax1w1-infected RSF were not significantly different; the means Ϯ SEM were 0.52 Ϯ 0.45, 0.69 Ϯ 0.60 and 0.60 Ϯ 0.67% respectively.
Nuclear DNA of RSF infected with the AxCAp21 or control viruses was fractionated with agarose gel electrophoresis. Whereas DNA of the apoptotic HL-60 cells had typical nucleosomal DNA ladders, the AxCAp21-infected or Ax1w1-infected RSF had no fragmented DNA (Fig. 2E) . These results argue that the p21 Cip1 overexpression did not induce apoptotic cell death of RSF.
Treatment of rat AA with adenoviral p21 Cip1 gene transfer
Six rats were immunized with M. butyricum to induce AA. They were treated with injection of AxCAp21 into the right knees and that of AxCALacZ into the left knees of the same animals. The gene transfer was carried out once (7 days after the immunization) or 3 times (8, 15 and 22 days after the immunization). Swelling of the knee joints was monitored during the disease course. The arthritis developed in all rats 10 days after the immunization. Without treatment, the knee joints width became maximal~20 days after the immunization and decreased afterwards. The knee joints treated with the control adenoviruses followed this course (Fig. 3) . In comparison, the gene p21 Cip1 transfer significantly suppressed swelling of the knees whether it was carried out once or 3 times (Fig. 3, P Ͻ 0.05) . The therapeutic effect lasted throughout the experiment to a statistically significant extent when the gene transfers were repeated 3 times with an interval of 1 week between transfers. Although the gene transfer carried out once also suppressed the joint swelling effectively, the effect became less clear after 2 weeks from the gene transfer.
To evaluate the effects of adenoviruses per se, the AxCALacZ viruses was injected into the right knee joints of normal rats. The same volume of saline was injected into the other knees. Either experiment induced no obvious joint swelling, and no difference in the width of the right and left knees was observed.
Effects of p21 Cip1 gene transfer on the histopathology of rat AA
The joints of the rats treated 3 times with the gene transfer were histologically examined 1 week after the last treatment. The synovial tissues of the knee joints from normal rats had one or two layers of synovial lining cells that were supported by loose fatty connective tissues (Fig. 4A) . The arthritic joints treated with AxCALacZ or with saline had marked synovial thickening, which was accompanied by mononuclear cell infiltration. Also, destructive pannus tissues developed and invaded the adjacent bones ( Fig. 4B and C) . The cartilage of the affected joints was degenerated. In contrast, synovial thickening and mononuclear cell infiltration were remarkably suppressed in the synovial tissues of the AxCAp21-treated joints (Fig. 4D) . Bone destruction by the pannus tissues was suppressed and cartilage was well preserved. The joints of normal rats which were treated with the control AxCALacZ viruses showed minimal and focal mononuclear cell infiltration, and slight stratification of the synovial lining cells (Fig. 4E) . No changes were observed in the joints treated with saline (Fig. 4F) .
Synovial thickness and cartilage thickness were measured, and infiltrating mononuclear cells were enumerated (4). Pannus invasion was scored for the severity. All of these measurements of the AxCAp21-treated and control LacZtreated joints showed that p21 Cip1 gene transfer significantly ameliorated the arthritis (Fig. 5) .
Injection of the AxCALacZ virus in the normal joints did not change synovial or cartilage thickness, or induce pannus formation. However, it induced a marginal but significant increase of the mononuclear cell infiltration; the means Ϯ SEM were 3.7 Ϯ 6.7 and 173 Ϯ 140/mm 2 in the saline-and the AxCALacZ-treated joints respectively. Since the mean number of infiltrating mononuclear cells in the residual synovitis was 643 Ϯ 516/mm 2 , the adenovirus appeared to contribute minimally to the residual inflammation, but not to the synovial thickening or the destruction of the bone and cartilage.
The cells in the S phase of cell cycle express PCNA. The arthritic synovial tissues were examined immunohistochemically for PCNA expression 1 week after the gene transfer. Synovial cells positive for PCNA staining were found more frequently in the synovial tissues of the AxCALacZtreated joints than in those of the AxCAp21-treated joints (Fig. 6A-D) . The PCNA LI, which reflect the frequency of the cells in the S phase, were calculated by examining three independent microscopic fields. They were significantly smaller in the AxCAp21-treated joints than in the AxCALacZtreated joints (Fig. 6E ).
Discussion
Our studies have shown that forced expression of the p21 Cip1 gene inhibits cell growth of RSF without inducing their apoptotic cell death. In vivo transfer of the p21 Cip1 gene into the synovial tissues suppressed the pathology of AA. These in vivo and in vitro effects were comparable to those of the p16 INK4a gene transfer. Reduced frequency of the PCNAexpressing cells in the p21 Cip1 -treated synovial tissues showed that the cell cycling of the synovial cells was indeed inhibited in vivo.
As was reviewed before, both p16 INK4a and p21 Cip1 are associated with replicative senescence. However, their expression is differentially regulated. p21 Cip1 inhibits a wider variety of CDKs than p16 INK4a . Moreover, their other biological effects than inhibition of kinase activity are distinct (9, 10, 28) . Disruption of the p16 INK4a gene, but not that of the p21 Cip1 gene, resulted in frequent tumor development in a murine model (29) . Nevertheless, the p16 INK4a and p21 Cip1 gene therapy ameliorated AA equally. They inhibited synovial thickening, mononuclear cell infiltration, pannus formation and cartilage degeneration. Thus, cell cycle control of the synovial cells by the senescence-related CDKI is effective to suppress pathology of the arthritis.
Generally, p21 Cip1 keeps cells from undergoing the apoptosis when the cells respond to various apoptosisinducing stimuli (30) (31) (32) . However, some immortalized cell lines died with apoptosis when they overexpressed the p21 Cip1 gene (15) (16) (17) (18) . The molecular events underlying the p21 Cip1 -induced apoptosis remain to be elucidated. In the rheumatoid synovial tissues, apoptotic cell death is observed commonly. However, when massive apoptosis of the synovial cells was induced artificially in animal models of RA, it ameliorated the pathology of the arthritis (33) (34) (35) . Thus, p21 Cip1 induction might have exerted therapeutic effects, at least partially, through induction of apoptosis.
In our experiments, the gene transfer was performed once or 3 times with an interval of 1 week between transfers. Repeated gene transfers were required to maintain the statistically significant therapeutic effects. This agrees with the observation that ectopic p21 Cip1 gene expression after the in vivo gene transfer was detectable only for 2-3 weeks (data not shown). Thus, anti-arthritic effects required sustained expression of p21 Cip1 . It was reported that induction of the p21 Cip1 gene in human fibrosarcoma cells affected expression of many genes (36) . Although the adenoviral p21 Cip1 gene transfer must have altered the gene expression by the synovial cells, the changes did not provide prolonged anti-rheumatic effects.
By p21 Cip1 transfer, mononuclear cell infiltration was also ameliorated. Lymphoid cells are generally resistant to the adenoviral infection. Indeed, in our experimental procedures, the recombinant adenoviruses delivered the exogene mainly to the synovial lining cells, and to some of the fibroblast-like and macrophage-like cells at the sublining and stromal area, but not to lymphoid cells (4) . Thus the reduction of the mononuclear cells should not be due to direct inhibition of their proliferation, but probably to overall suppression of the synovial inflammation.
It should be noted that the gene transfer protocol in the present study was not necessarily optimized. Adenoviral gene transfer was applied because it introduces exogenes to the synovial cells with high efficacy (37) . The aim of the present studies was to investigate the therapeutic effect of the p21 Cip1 induction in the inflamed synovial tissues. For actual application to human RA, the gene delivery method should be improved. Injection of the adenoviruses into joints could induce inflammatory responses (37) . Indeed, we observed residual synovitis in the AxCAp21-treated joints and minimal mononuclear cell infiltration in the joints of normal rats treated with the control adenoviruses. Thus, the residual synovitis in AxCAp21-treated joints might be partly attributable to the inflammatory effects of the adenoviruses. Although the therapeutic effects of CDKI gene transfer surpassed the inflammatory effects of the adenoviruses, it is desirable to use less inflammatory variants of the adenoviruses (38) .
Little is understood about regulation of the p16 INK4a gene expression. Inactivation of retinoblastoma gene product (pRB) by viral gene products promotes transcription of p16 INK4a (39) . However, responsive promoter elements for this induction are still unclear (39) . A few methods that induce p16 INK4a gene expression in pre-senescent cells include γ-irradiation, bleomycin and actinomycin D treatment of certain cell lines (5, 40) . In contrast, multiple compounds have been identified to induce p21 Cip1 in many cell lines (41) (42) (43) (44) (45) . The p21 Cip1 gene is also induced by serum, growth factors and IL-6 in some cell lines (46, 47) . Thus, development of pharmaceuticals to induce p21 Cip1 expression in vivo in the synovial tissues might be more feasible. However, unlike p16 INK4a , p21 Cip1 is readily induced in the fibroblasts of non-synovial origin (4, 5, 8) . Since generalized p21 Cip1 induction will probably impair homeostasis of the body, the induction should be confined within the inflamed synovial tissues by some means.
The gene therapy reported here aims at transforming synovial cells per se and is thus distinct from the previous trials, which were mostly to produce anti-inflammatory molecules in the joints (48) (49) (50) (51) (52) (53) (54) . It was shown that the intra-articular delivery of the anti-inflammatory cytokine and cytokine antagonist genes could exert their effects on non-treated joints (54) (55) (56) . Such a remote effect was not observed in our experiments (data not shown). However, this was expected because the products of the p21 Cip1 gene should not be released from the virus-infected cells.
In theory, gene delivery of other cell-cycle regulators could be likewise effective in treating the arthritis. Nevertheless, as for the development of new anti-rheumatic drugs, p21 Cip1 and p16 INK4a appear to be attractive target candidates because they are inducible in RSF.
